At the transcriptional level, AEG-1/MTDH levels may be increased in gastric cancer tissue samples, but with considerable heterogeneity, and it may have the potential to be used as a target for diagnostic/therapeutic purposes only in a subset of patients (76). Here, MTDH is linked to gastric cancer.